Insulin, GLP-1 and oral hypoglycaemic agents Flashcards
1
Q
Aim of diabetes treatment
A
- education for self management
- focus on lifestyle and diet changes
- psychological and social support
- CV RF control avoiding complications
- regularly screening for complications
2
Q
Diabetic Annual Review
A
- min. twice a year
- symptom review
- clinical issues review (glucose levels, BP, cholesterol, ACR in urine)
- screen for comp (eyes, feet, kidneys)
- identify issues at subsequent visit
- develop targets over next year
3
Q
Treatment to prevent complications
A
- smoking cessation (1 cig = 5 If diabetes)
- aim for 140/80 bp, 130/80 if CVD or renal d, use ACEi/CCB and need >2 bp treatments
- statin if diabetic >40 or <40 + RF for high cholesterol, aim for <4mmol/L and LDL <2 mmol/L
- yearly digital retinal photography
- yearly nerves and pulses in feet
- yearly ACR and estimate GFR
4
Q
How to assess glycaemic control?
A
- HbA1c = red cells survive 3 months, less than 53 mmol/mol good control
- SMBG = pre-prandial 4-7, post prandial 2 hour glucose 5-9
- fructosamine = 2 weeks glycated protein, if HbA1c invalid as haemoglobinopathy and useful in pregnancy glucose monitoring
5
Q
Diet and exercise advice for diabetes treatment
A
- low fat
- low sugar
- low salt
- high in fibre
- fruit and veg
- low carbs = low GI
- 30 mins vigorous exercise 3x a week
- aim for 3-5% weight reduction for glycemic control
- early oral hypoglycaemic agents if diet and lifestyle strategy fails
6
Q
Hyperglycaemia therapies
A
- sulfonylureas
- biguanides
- alpha glucosidase inhibitors
- TZD (glitazones)
- DPP4 inhibitors
- GLP-1 analogues
- insulin
7
Q
What is the United Kingdom Prospective Diabetes Study
A
- tight vs standard glycemic control
- microvascular disease reduced
- little effect on macrovascular disease
8
Q
How do sulfonylureas and PGRs work in the pancreas?
A
- insulin secretagogues
- stimulate insulin release from beta cells
- through opening K+ channels in beta cells
- side effects = weight gain, hypoglycaemia
9
Q
How do biguanides work?
A
- metformin
- improved insulin sensitivity in muscle and liver so can uptake glucose
- first line for T2D in majority
- reduces mortality
- reduces weight
- sometimes reduces cancer
- be wary with renal disease and don’t give if eGFR <30 as renally excreted and not cleared from blood
10
Q
How do alpha-glucosidase inhibitors work?
A
- drugs inhibiting intestinal absorption of glucose by blocking dissacharidases so stop converting to mono
- lower serum glucose levels
- but glucose moves into lower bowel attracting bacteria = wind
11
Q
How do TZD work?
A
- glitazones
- PPRGamma receptor agonists
- improve insulin resistance
- work on liver and muscle
- improve glucose uptake
- help pancreas B cell function and content
12
Q
What do GLP-1’s do?
A
- incretin
- increase insulin
- stimulate insulin from pancreas
- decrease glucagon secretion
- delay gastric emptying
- suppress appetite
13
Q
What is exendin-4?
A
- GLP-1 analogue
- injection
- suppresses appetite and stimulates insulin release
- only if BMI>35kg/m2 and poor glucose control
14
Q
What DPP-4 inhibitors do?
A
- gliptins
- inhibit enzyme breaking down GLP-1
- oral
- well tolerated
- 3rd line therapy
15
Q
When do we use different drugs according to NICE guidelines?
A
- first line metformin
- second add sulfonylurea
- third glitazone/gliptin/insuin
- then insulin + metformin + sulfonylurea